Hardy Céline S C, Bahr Lauren E, Rothman Alan L, Anderson Kathryn B, Barba-Spaeth Giovanna, Weiskopf Daniela, Ooi Eng Eong, Marques Ernesto T A, Bonsignori Mattia, Barrett Alan D T, Kirkpatrick Beth D, Castanha Priscila M S, Hamins-Puertolas Marco, Christofferson Rebecca C, Dimopoulos George, Oliveira Fabiano, Chiang Lillian W, Ko Albert I, Gunale Bhagwat, Kulkarni Prasad, Perkins T Alex, Dorigatti Ilaria, Stewart Telisa, Shaw Jana, Johansson Michael A, Thomas Stephen J, Waickman Adam T
Department of Microbiology and Immunology, Upstate Medical University, Syracuse, New York, United States of America.
Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island, Kingston, Rhode Island, United States of America.
PLoS Negl Trop Dis. 2025 Apr 28;19(4):e0013028. doi: 10.1371/journal.pntd.0013028. eCollection 2025 Apr.
On August 7-9, 2024, the second annual dengue "endgame" summit was held in Syracuse, NY, hosted by the Global Health Institute at SUNY Upstate Medical University. The meeting brought together attendees from around the world, with talks spanning healthcare, government control programs, basic research, and medical countermeasure development efforts. The summit goal was to work toward a better understanding of what dengue control could look like and the steps required to reach such a goal. The objectives of the meeting were to discuss the current global state of dengue, what dengue "control" might look like, and to discuss actionable pathways for achieving dengue control. Topics covered throughout the meeting included DENV immunity and pathogenesis, challenges in countermeasure development, innovative vector control strategies, dengue diagnostics, addressing challenges in science communication, and vaccine hesitancy. Several fundamental knowledge gaps were repeatedly highlighted by the summit attendees and were cited as critical barriers to the development, deployment, and evaluation of effective dengue countermeasures. These gaps include (1) the lack of a broadly applicable immunologic biomarker/correlate of DENV immunity and (2) the lack of universally accepted/applicable metrics for quantifying dengue severity in the setting of countermeasure evaluations. In addition, the lack of clear and consistent international leadership in the global dengue control effort was cited as a barrier to widespread and synergistic research and countermeasure development/deployment activities. Despite these persistent roadblocks, summit attendees expressed optimism that holistic and multi-tiered approaches-incorporating optimal use of existing and nascent countermeasure technologies deployed in collaboration with local communities-could be effective in progressing toward dengue control.
2024年8月7日至9日,第二届年度登革热“终结”峰会在纽约州锡拉丘兹举行,由纽约州立大学上州医科大学全球健康研究所主办。会议汇聚了来自世界各地的与会者,讨论内容涵盖医疗保健、政府防控项目、基础研究以及医学对策开发工作。峰会的目标是努力更好地理解登革热防控可能的样子以及实现这一目标所需的步骤。会议的目的是讨论登革热的当前全球状况、登革热“防控”可能是什么样,并讨论实现登革热防控的可行途径。会议涵盖的主题包括登革病毒免疫和发病机制、对策开发中的挑战、创新的病媒控制策略、登革热诊断、应对科学传播中的挑战以及疫苗犹豫问题。峰会与会者多次强调了几个基本的知识空白,并将其视为有效登革热对策开发、部署和评估的关键障碍。这些空白包括:(1)缺乏广泛适用的免疫生物标志物/登革病毒免疫相关指标;(2)在对策评估中缺乏普遍接受/适用的量化登革热严重程度的指标。此外,全球登革热防控努力缺乏明确和一致的国际领导被认为是广泛和协同的研究以及对策开发/部署活动的障碍。尽管存在这些持续的障碍,峰会与会者表示乐观地认为,结合与当地社区合作最佳利用现有和新兴对策技术的整体和多层次方法,可能有效地推动登革热防控工作取得进展。